Business Context and Reporting Period
ImmuCell Corporation (ICCC), a Delaware corporation, filed this Form 8-K on August 7, 2025, to report the entry into a material definitive agreement and the creation of a direct financial obligation. The company is headquartered in Portland, Maine, and its common stock trades on the NASDAQ Capital Market.
Key Financial Metrics and Transaction Details
The filing details a new loan transaction with Maine Community Bank (MCB) executed on August 7, 2025. Key terms include:
- New Loan Principal: $2,327,119
- Interest Rate: 6.5% per annum (fixed)
- Collateral: Secured by a security interest in substantially all of the Company's assets.
- Use of Proceeds: Refinancing of existing debt obligations.
The filing does not provide current revenue, profit, cash flow, or liquidity metrics beyond the specific debt transaction details.
Material Changes and Debt Restructuring
The new loan was utilized to pay off two existing loans, resulting in a reduction of the weighted average interest rate and a consolidation of debt:
- Retired MCB Loan: $1,525,852 outstanding balance at 7% interest.
- Retired FAME Loan: $768,209 outstanding balance at 8% interest.
- Total Retired Debt: $2,294,061
- Net Increase in Principal: $33,058 (New principal of $2,327,119 minus retired principal of $2,294,061).
This transaction reduces the company's interest expense burden by replacing higher-rate debt (7% and 8%) with a lower-rate instrument (6.5%).
Risks, Contingencies, and Covenants
The filing highlights specific risks associated with the new agreement:
- Default Risk: Failure to make timely principal and interest payments or non-compliance with agreement terms will entitle MCB to accelerate the debt maturity and demand full repayment.
- Asset Security: The loan is secured by substantially all company assets, increasing the risk of asset seizure in the event of default.
The filing does not contain forward-looking guidance, management commentary on future operations, or discussion of other contingencies.
Investor Verification Checklist
- Verify the full terms of the Loan Agreement (Exhibit 10.1) and Promissory Note (Exhibit 10.2) for specific repayment schedules and covenants.
- Confirm the company's current cash position to ensure ability to service the new $2.3M debt obligation at 6.5% interest.
- Review the August 12, 2025 Press Release (Exhibit 99.1) for additional context on the refinancing strategy.
- Assess the impact of the asset lien on future financing capabilities or potential asset sales.